Mitogen-activated protein kinases in innate immunity (original) (raw)

• Newton, K. & Dixit, V. M. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 4, a006049 (2012).
  PubMed PubMed Central Google Scholar
• Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 11, 373–384 (2010).
  CAS Google Scholar
• Iwasaki, A. & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291–295 (2010).
  CAS PubMed PubMed Central Google Scholar
• Medzhitov, R. & Horng, T. Transcriptional control of the inflammatory response. Nature Rev. Immunol. 9, 692–703 (2009).
  CAS Google Scholar
• Tseng, P. H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunol. 11, 70–75 (2010).
  CAS Google Scholar
• Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001). This is the first study to establish a role for K63-linked ubiquitylation in MAPK signalling.
  CAS Google Scholar
• Sakurai, H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 33, 522–530 (2012).
  CAS PubMed Google Scholar
• Ajibade, A. A. et al. TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Immunity 36, 1–12 (2012).
  Google Scholar
• Shim, J. H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668–2681 (2005).
  CAS PubMed PubMed Central Google Scholar
• Sato, S. et al. Essential function of the kinase TAK1 in innate and adaptive immune responses. Nature Immunol. 6, 1087–1095 (2005). References 8 and 10 highlight the complex cell type-specific roles of TAK1 in MAPK and NF-κB activation by TLRs.
  CAS Google Scholar
• Mendoza, H. et al. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem. J. 409, 711–722 (2008).
  CAS PubMed Google Scholar
• Omori, E., Inagaki, M., Mishina, Y., Matsumoto, K. & Ninomiya-Tsuji, J. Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species. Proc. Natl Acad. Sci. USA 109, 3365–3370 (2012).
  CAS PubMed Google Scholar
• Ori, D. et al. Essential roles of K63-linked polyubiquitin-binding proteins TAB2 and TAB3 in B cell activation via MAPKs. J. Immunol. 190, 4037–4045 (2013).
  CAS PubMed Google Scholar
• Eftychi, C., Karagianni, N., Alexiou, M., Apostolaki, M. & Kollias, G. Myeloid TAKL acts as a negative regulator of the LPS response and mediates resistance to endotoxemia. PLoS ONE 7, e31550 (2012).
  CAS PubMed PubMed Central Google Scholar
• Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nature Rev. Immunol. 10, 170–181 (2010).
  CAS Google Scholar
• Greten, F. R. et al. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKK. Cell 130, 918–931 (2007).
  CAS PubMed PubMed Central Google Scholar
• Matsuzawa, A. et al. ROS-dependent activation of the TRAF6–ASK1–p38 pathway is selectively required for TLR4-mediated innate immunity. Nature Immunol. 6, 587–592 (2005).
  CAS Google Scholar
• Mnich, S. J. et al. Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis. Int. Immunopharmacol. 10, 1170–1176 (2010).
  CAS PubMed Google Scholar
• Noguchi, T. et al. Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J. Biol. Chem. 280, 37033–37040 (2005).
  CAS PubMed Google Scholar
• Fujino, G. et al. Thioredoxin and TRAF family protiens regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interactioin of ASK1. Mol. Cell. Biol. 27, 8152–8163 (2007).
  CAS PubMed PubMed Central Google Scholar
• Noh, K. T., Park, Y. M., Cho, S. G. & Choi, E. J. GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock. Exp. Cell Res. 317, 1663–1668 (2011).
  CAS PubMed Google Scholar
• Nakamura, K., Kimple, A. J., Siderovski, D. P. & Johnson, G. L. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-κB activation. J. Biol. Chem. 285, 2077–2089 (2010).
  CAS PubMed Google Scholar
• Huang, Q. et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nature Immunol. 5, 98–103 (2004).
  CAS Google Scholar
• Kim, K., Duramad, O., Qin, X. F. & Su, B. MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages. Immunology 120, 242–250 (2007).
  CAS PubMed PubMed Central Google Scholar
• Gantke, T., Sriskantharajah, S., Sadowski, M. & Ley, S. C. IκB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246, 168–182 (2012).
  PubMed Google Scholar
• Beinke, S. et al. NF-κB p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23, 4739–4752 (2003).
  CAS PubMed PubMed Central Google Scholar
• Waterfield, M. R., Zhang, M., Norman, L. P. & Sun, S.-C. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the TPL-2 kinase. Mol. Cell 11, 685–694 (2003).
  CAS PubMed Google Scholar
• Beinke, S., Robinson, M. J., Hugunin, M. & Ley, S. C. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24, 9658–9667 (2004).
  CAS PubMed PubMed Central Google Scholar
• Robinson, M. J., Beinke, S., Kouroumalis, A., Tsichlis, P. N. & Ley, S. C. Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Mol. Cell. Biol. 27, 7355–7364 (2007).
  CAS PubMed PubMed Central Google Scholar
• Roget, K. et al. IKK2 regulates TPL-2 activation of ERK-1/2 MAP kinases by direct phosphorylation of TPL-2 serine 400. Mol. Cell. Biol. 32, 4684–4690 (2012). References 26–30 establish the direct regulation of TPL2 activation by IKK2-mediated phosphorylation of p105, showing a direct link between ERK1 and ERK2 activation and NF-κB activation in TLR-stimulated macrophages.
  CAS PubMed PubMed Central Google Scholar
• Rincon, M. & Davis, R. J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 228, 212–224 (2009).
  CAS PubMed Google Scholar
• Han, M. S. et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218–222 (2013). This is the first study to provide clear genetic evidence of a role for JNK in regulating gene expression in TLR-stimulated macrophages.
  CAS PubMed Google Scholar
• Martinez, F. O., Helming, L. & Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451–483 (2009).
  CAS PubMed Google Scholar
• Odegaard, J. I. & Chawla, A. Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275–297 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dumitru, C. D. et al. TNFα induction by LPS is regulated post-transcriptionally via a TPL2/ERK-dependent pathway. Cell 103, 1071–1083 (2000).
  CAS PubMed Google Scholar
• Kaiser, F. et al. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863–1871 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mielke, L. A. et al. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 production. J. Immunol. 183, 7984–7993 (2009).
  CAS PubMed PubMed Central Google Scholar
• Yang, H. T. et al. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105. Mol. Cell. Biol. 32, 3438–3451 (2012).
  CAS PubMed PubMed Central Google Scholar
• Cohen, P. Targeting protein kinases for the development of anti-inflammatory drugs. Curr. Opin. Cell Biol. 21, 1–8 (2009).
  Google Scholar
• Beardmore, V. A. et al. Generation and characterization of p38β (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25, 10454–10464 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kang, Y. J. et al. Macrophage deletion of p38α partially impairs lipopolysaccharide-induced cellular activation. J. Immunol. 180, 5075–5082 (2008).
  CAS PubMed Google Scholar
• O'Keefe, S. J. et al. Chemical genetics define the roles of p38 and p38β in acute and chronic inflammation. J. Biol. Chem. 282, 34663–34671 (2007). This elegant study uses chemical genetics to establish that the anti-inflammatory effects of p38 inhibitors are mediated via p38α.
  CAS PubMed Google Scholar
• Kim, C. et al. The kinase p38α serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nature Immunol. 9, 1019–1027 (2008).
  CAS Google Scholar
• Guma, M. et al. Pro- and anti-inflammatory functions of the p38 pathway in rheumatoid arthritis: Advantages of targeting upstream kinases MKK3 or MKK6. Arthritis Rheum. 64, 2887–2895 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bohm, C. et al. The α-isoform of p38 MAPK specifically regulates arthritic bone loss. J. Immunol. 183, 5938–5947 (2009).
  PubMed Google Scholar
• Ananieva, O. et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nature Immunol. 9, 1028–1036 (2008). Reference 44 and 46 provide genetic evidence for both pro- and anti-inflammatory roles for p38α, and the roles of MSK1 and MSK2 downstream of p38α, in regulating IL-10 production.
  CAS Google Scholar
• Cheung, P. C., Campbell, D. G., Nebreda, A. R. & Cohen, P. Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793–5805 (2003).
  CAS PubMed PubMed Central Google Scholar
• Gonzalez-Teran, B. et al. Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. J. Clin. Invest. 123, 164–178 (2013).
  CAS PubMed Google Scholar
• Risco, A. et al. p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. Proc. Natl Acad. Sci. USA 109, 11200–11205 (2012). This study describes the surprising requirement for p38γ and p38δ for the maintenance of TPL2 protein levels in myeloid cells.
  CAS PubMed Google Scholar
• Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nature Cell Biol. 1, 94–97 (1999).
  CAS PubMed Google Scholar
• Hitti, E. et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26, 2399–2407 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tiedje, C. et al. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet. 8, e1002977 (2012). This study establishes how p38α regulates Tnf translation via MK2 phosphorylation of tristetraprolin.
  CAS PubMed PubMed Central Google Scholar
• Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387–398 (1999).
  CAS PubMed Google Scholar
• Carballo, E., Gilkeson, G. S. & Blackshear, P. J. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (−/−) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFα overproduction. J. Clin. Invest. 100, 986–995 (1997).
  CAS PubMed PubMed Central Google Scholar
• Qiu, L. Q., Stumpo, D. J. & Blackshear, P. J. Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype. J. Immunol. 188, 5150–5159 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ronkina, N. et al. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27, 170–181 (2007).
  CAS PubMed Google Scholar
• Ronkina, N. et al. Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res. 39, 2503–2518 (2010).
  PubMed PubMed Central Google Scholar
• Zaru, R., Ronkina, N., Gaestel, M., Arthur, J. S. & Watts, C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nature Immunol. 8, 1227–1235 (2007).
  CAS Google Scholar
• Darragh, J., Ananieva, O., Courtney, A., Elcombe, S. & Arthur, J. S. MSK1 regulates the transcription of IL-1ra in response to TLR activation in macrophages. Biochem. J. 425, 595–602 (2010).
  CAS PubMed Google Scholar
• Mackenzie, K. F. et al. MSK1 and 2 inhibit LPS induced prostaglandin production via an IL-10 feedback loop. Mol. Cell. Biol. 33, 1456–1467 (2013).
  CAS PubMed PubMed Central Google Scholar
• Brook, M. et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol. Cell. Biol. 26, 2408–2418 (2006).
  CAS PubMed PubMed Central Google Scholar
• MacKenzie, K. F. et al. PGE2 induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway. J. Immunol. 190, 565–577 (2013).
  CAS PubMed PubMed Central Google Scholar
• Alvarez, Y., Municio, C., Alonso, S., Sanchez Crespo, M. & Fernandez, N. The induction of IL-10 by zymosan in dendritic cells depends on CREB activation by the coactivators CREB-binding protein and TORC2 and autocrine PGE2. J. Immunol. 183, 1471–1479 (2009).
  CAS PubMed Google Scholar
• Caunt, C. J. & Keyse, S. M. Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS J. 280, 489–504 (2012).
  PubMed Google Scholar
• Liu, Y., Shepherd, E. G. & Nelin, L. D. MAPK phosphatases--regulating the immune response. Nature Rev. Immunol. 7, 202–212 (2007).
  CAS Google Scholar
• Rodriguez, N. et al. Increased inflammation and impaired resistance to Chlamydophila pneumoniae infection in _Dusp1_−/− mice: critical role of IL-6. J. Leukoc. Biol. 88, 579–587 (2010).
  CAS PubMed Google Scholar
• Hammer, M. et al. Increased inflammation and lethality of _Dusp1_−/− mice in polymicrobial peritonitis models. Immunology 131, 395–404 (2010).
  CAS PubMed PubMed Central Google Scholar
• Frazier, W. J. et al. Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice. J. Immunol. 183, 7411–7419 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Knockout of Mkp-1 enhances the host inflammatory responses to Gram-positive bacteria. J. Immunol. 178, 5312–5320 (2007).
  CAS PubMed Google Scholar
• Hammer, M. et al. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur. J. Immunol. 35, 2991–3001 (2005).
  CAS PubMed Google Scholar
• Valledor, A. F. et al. IFN-γ-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. Blood 112, 3274–3282 (2008).
  CAS PubMed Google Scholar
• Lee, C. H. et al. Glutamine suppresses airway neutrophilia by blocking cytosolic phospholipase A2 via an induction of MAPK phosphatase-1. J. Immunol. 189, 5139–5146 (2012).
  CAS PubMed Google Scholar
• Ayush, O. et al. Glutamine suppresses DNFB-induced contact dermatitis by deactivating p38 mitogen-activated protein kinase via induction of MAPK phosphatase-1. J. Invest. Dermatol. 133, 723–731 (2013).
  CAS PubMed Google Scholar
• Ko, H. M. et al. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1. J. Immunol. 182, 7957–7962 (2009).
  CAS PubMed Google Scholar
• Abraham, S. M. et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883–1889 (2006).
  CAS PubMed PubMed Central Google Scholar
• Maier, J. V. et al. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol. Endocrinol. 21, 2663–2671 (2007).
  CAS PubMed Google Scholar
• Wang, X. et al. The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci. 83, 671–680 (2008).
  CAS PubMed PubMed Central Google Scholar
• Cao, W., Bao, C., Padalko, E. & Lowenstein, C. J. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J. Exp. Med. 205, 1491–1503 (2008). This is the first work to establish that DUSPs can be regulated by acetylation.
  CAS PubMed PubMed Central Google Scholar
• Jeffrey, K. L. et al. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nature Immunol. 7, 274–283 (2006).
  CAS Google Scholar
• Cornell, T. T., Rodenhouse, P., Cai, Q., Sun, L. & Shanley, T. P. Mitogen-activated protein kinase phosphatase 2 regulates the inflammatory response in sepsis. Infect. Immun. 78, 2868–2876 (2010).
  CAS PubMed PubMed Central Google Scholar
• Al-Mutairi, M. S. et al. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 6, e1001192 (2010).
  PubMed PubMed Central Google Scholar
• Grasset, M. F., Gobert-Gosse, S., Mouchiroud, G. & Bourette, R. P. Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5. J. Leukoc. Biol. 87, 127–135 (2010).
  CAS PubMed Google Scholar
• Zhang, Y. et al. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430, 793–797 (2004).
  CAS PubMed Google Scholar
• Qian, F. et al. A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J. 28, 2896–2907 (2009).
  CAS PubMed PubMed Central Google Scholar
• Guo, T. et al. The role of male chromosomal polymorphism played in spermatogenesis and the outcome of IVF/ICSI-ET treatment. Int. J. Androl. 35, 802–809 (2012).
  CAS PubMed Google Scholar
• Roy, C. R. & Mocarski, E. S. Pathogen subversion of cell-intrinsic innate immunity. Nature Immunol. 8, 1179–1187 (2007).
  CAS Google Scholar
• Turk, B. E. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 402, 405–417 (2007).
  CAS PubMed Google Scholar
• Ali, S. R. et al. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 35, 34–44 (2011).
  CAS PubMed PubMed Central Google Scholar
• Halle, M. et al. The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J. Biol. Chem. 284, 6893–6908 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ma, L. et al. An evolutionary analysis of trypanosomatid GP63 proteases. Parasitol. Res. 109, 1075–1084 (2011).
  PubMed Google Scholar
• Schorey, J. S. & Cooper, A. M. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell. Microbiol. 5, 133–142 (2003).
  CAS PubMed Google Scholar
• Kim, K. H. et al. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc. Natl Acad. Sci. USA 109, 7729–7734 (2010).
  Google Scholar
• Trosky, J. E., Liverman, A. D. & Orth, K. Yersinia outer proteins: yops. Cell. Microbiol. 10, 557–565 (2008).
  CAS PubMed Google Scholar
• Mukherjee, S. et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312, 1211–1214 (2006).
  CAS PubMed Google Scholar
• Mittal, R., Peak-Chew, S. Y. & McMahon, H. T. Acetylation of MEK2 and IκB kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl Acad. Sci. USA 103, 18574–18579 (2006).
  CAS PubMed Google Scholar
• Paquette, N. et al. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl Acad. Sci. USA 109, 12710–12715 (2012). References 94–96 describe how Yersinia YopJ inhibits MAPK activation by the acetylation of MKKs.
  CAS PubMed Google Scholar
• Trosky, J. E. et al. VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J. Biol. Chem. 282, 34299–34305 (2007).
  CAS PubMed Google Scholar
• Jones, R. M. et al. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3, 233–244 (2008).
  CAS PubMed Google Scholar
• Mazurkiewicz, P. et al. SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol. Microbiol. 67, 1371–1383 (2008).
  CAS PubMed PubMed Central Google Scholar
• Li, H. et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 315, 1000–1003 (2007).
  CAS PubMed Google Scholar
• Zhu, Y. et al. Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol. Cell 28, 899–913 (2007). References 99–101 establish that S. enterica - and Shigella spp.-encoded phosphothreonine lyases irreversibly inactivate MAPKs to modulate host immune responses.
  CAS PubMed Google Scholar
• Brennan, D. F. & Barford, D. Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases. Trends Biochem. Sci. 34, 108–114 (2009).
  CAS PubMed Google Scholar
• Reiterer, V. et al. Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection. Cell. Signal. 23, 1188–1196 (2011).
  CAS PubMed Google Scholar
• Odendall, C. et al. The Salmonella kinase SteC targets the MAP kinase MEK to regulate the host actin cytoskeleton. Cell Host Microbe 12, 657–668 (2012). This study describes how SteC kinase modulates S. enterica virulence by activating ERK1 and ERK2 via direct phosphorylation of MKK1 and MKK2.
  CAS PubMed PubMed Central Google Scholar
• Figueira, R. & Holden, D. W. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology 158, 1147–1161 (2012).
  CAS PubMed Google Scholar
• Dar, A. C. & Shokat, K. M. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu. Rev. Biochem. 80, 769–795 (2011).
  CAS PubMed Google Scholar
• Goldstein, D. M., Kuglstatter, A., Lou, Y. & Soth, M. J. Selective p38α inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J. Med. Chem. 53, 2345–2353 (2010).
  CAS PubMed Google Scholar
• Genovese, M. C. et al. A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis. J. Rheumatol. 38, 846–854 (2011).
  CAS PubMed Google Scholar
• Cohen, S. B. et al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheum. 60, 335–344 (2009).
  CAS PubMed Google Scholar
• Damjanov, N., Kauffman, R. S. & Spencer-Green, G. T. Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis Rheum. 60, 1232–1241 (2009).
  PubMed Google Scholar
• Lomas, D. A. et al. An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. J. Clin. Pharmacol. 52, 416–424 (2012).
  CAS PubMed Google Scholar
• Anand, P. et al. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur. J. Pain 15, 1040–1048 (2011).
  CAS PubMed Google Scholar
• Ninomiya-Tsuji, J. et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278, 18485–18490 (2003).
  CAS PubMed Google Scholar
• Pauls, E. et al. Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cells. J. Biol. Chem. 287, 19216–19228 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hegen, M., Gaestel, M., N. Ickerson-Nutter, C. L., Lin, L. L. & Telliez, J. B. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J. Immunol. 177, 1913–1917 (2006).
  CAS PubMed Google Scholar
• Mourey, R. J. et al. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor-α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J. Pharmacol. Exp. Ther. 333, 797–807 (2010).
  CAS PubMed Google Scholar
• Thiel, M. J. et al. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms. Arthritis Rheum. 56, 3347–3357 (2007).
  CAS PubMed Google Scholar
• George, D. & Salmeron, A. Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease. Curr. Top. Med. Chem. 9, 611–622 (2009).
  CAS PubMed Google Scholar
• Kontoyiannis, D. et al. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196, 1563–1574 (2002).
  CAS PubMed PubMed Central Google Scholar
• Zhang, T. et al. Discovery of potent and selective covalent inhibitors of JNK. Chem. Biol. 19, 140–154 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wilhelmsen, K., Mesa, K. R., Lucero, J., Xu, F. & Hellman, J. ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes. J. Biol. Chem. 287, 26478–26494 (2012).
  CAS PubMed PubMed Central Google Scholar
• Carlson, S. M. et al. Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation of ETV3. Sci. Signal. 4, rs11 (2011).
  PubMed PubMed Central Google Scholar
• Cargnello, M. & Roux, P. P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50–83 (2011).
  CAS PubMed PubMed Central Google Scholar
• O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604–1609 (2007).
  CAS PubMed Google Scholar
• Fleming, Y. et al. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J. 352, 145–154 (2000).
  CAS PubMed PubMed Central Google Scholar
• Tournier, C. et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15, 1419–1426 (2001).
  CAS PubMed PubMed Central Google Scholar
• Zou, H. et al. Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins. FEBS Lett. 581, 196–202 (2007).
  CAS PubMed Google Scholar
• Bardwell, L. Mechanisms of MAPK signalling specificity. Biochem. Soc. Trans. 34, 837–841 (2006).
  CAS PubMed PubMed Central Google Scholar
• Symons, A., Beinke, S. & Ley, S. C. MAP kinase kinase kinases and innate immunity. Trends Immunol. 27, 40–48 (2006).
  CAS PubMed Google Scholar
• Dhanasekaran, D. N., Kashef, K., Lee, C. M., Xu, H. & Reddy, E. P. Scaffold proteins of MAP-kinase modules. Oncogene 26, 3185–3202 (2007).
  CAS PubMed Google Scholar
• Paul, A. et al. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell. Signal. 11, 491–497 (1999).
  CAS PubMed Google Scholar
• Caivano, M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett. 429, 249–253 (1998).
  CAS PubMed Google Scholar
• Chan, E. D. et al. Induction of inducible nitric oxide synthase-NO• by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect. Immun. 69, 2001–2010 (2001).
  CAS PubMed PubMed Central Google Scholar
• Chen, C., Chen, Y. H. & Lin, W. W. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97, 124–129 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245–313 (2007).
  CAS PubMed Google Scholar
• El-Benna, J., Dang, P. M., Gougerot-Pocidalo, M. A., Marie, J. C. & Braut-Boucher, F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp. Mol. Med. 41, 217–225 (2009).
  CAS PubMed PubMed Central Google Scholar
• Laroux, F. S., Romero, X., Wetzler, L., Engel, P. & Terhorst, C. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of Gram-negative bacteria. J. Immunol. 175, 5596–5600 (2005).
  CAS PubMed Google Scholar
• Dang, P. M. et al. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J. Clin. Invest. 116, 2033–2043 (2006).
  CAS PubMed PubMed Central Google Scholar
• Parsa, K. V., Butchar, J. P., Rajaram, M. V., Cremer, T. J. & Tridandapani, S. The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk. Mol. Immunol. 45, 3012–3021 (2008).
  CAS PubMed PubMed Central Google Scholar
• Blander, J. M. & Medzhitov, R. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304, 1014–1018 (2004).
  CAS PubMed Google Scholar
• Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098–1109 (2009).
  CAS PubMed Google Scholar
• Emmerich, C.H., Schmukle, A.C. & Walczak, H. The emerging role of linear ubiquitination in cell signaling. Sci. Signal. 4, re5 (2011).
  PubMed Google Scholar
• Zak, D.E. et al. Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc. Natl Acad. Sci. USA 108, 11536–11541 (2011).
  CAS PubMed Google Scholar
• Brondello, J. M., Pouyssegur, J. & McKenzie, F. R. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514–2517 (1999).
  CAS PubMed Google Scholar
• Lin, Y. W. & Yang, J. L. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J. Biol. Chem. 281, 915–926 (2006).
  CAS PubMed Google Scholar
• Zhou, B. et al. Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents. Proc. Natl Acad. Sci. USA 107, 4573–4578 (2010).
  CAS PubMed Google Scholar
• Guo, X. et al. Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway. EMBO Mol. Med. 2, 504–515 (2010).
  CAS PubMed PubMed Central Google Scholar
• Sebolt-Leopold, J. S. Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway. Clin. Cancer Res. 14, 3651–3656 (2008).
  CAS PubMed Google Scholar
• Flaherty, K. T. et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N. Engl. J. Med. 367, 107–114 (2012).
  CAS PubMed Google Scholar